Abstract | BACKGROUND: RESULTS: The present study investigated the echinocandin susceptibility of 1650 C. glabrata clinical isolates in China from August 2014 to July 2019. The in vitro activity of micafungin was significantly better than those of caspofungin and anidulafungin (P < 0.001), assessed by MIC50/90 values. Whole genome sequencing was conducted on non-susceptible isolates and geography-matched susceptible isolates. Thirteen isolates (0.79%) were resistant to at least one echinocandin. Six isolates (0.36%) were solely intermediate to caspofungin. Common evolutionary analysis of echinocandin-resistant and echinocandin-intermediate isolates revealed genes related with reduced caspofungin sensitivity, including previously identified sphinganine hydroxylase encoding gene SUR2. Genome-wide association study identified SNPs at subtelometric regions that were associated with echinocandin non-susceptibility. In-host evolution of echinocandin resistance of serial isolates revealed an enrichment for non-synonymous mutations in adhesins genes and loss of subtelometric regions containing adhesin genes. CONCLUSIONS: The echinocandins are highly active against C. glabrata in China with a resistant rate of 0.79%. Echinocandin non-susceptible isolates carried common evolved genes which are related with reduced caspofungin sensitivity. In-host evolution of C. glabrata accompanied intensive changing of adhesins profile.
|
Authors | Yi Li, Xin Hou, Ruoyu Li, Kang Liao, Ling Ma, Xiaoming Wang, Ping Ji, Haishen Kong, Yun Xia, Hui Ding, Wei Kang, Ge Zhang, Jin Li, Meng Xiao, Yingxing Li, Yingchun Xu |
Journal | BMC microbiology
(BMC Microbiol)
Vol. 23
Issue 1
Pg. 341
(Nov 16 2023)
ISSN: 1471-2180 [Electronic] England |
PMID | 37974063
(Publication Type: Multicenter Study, Journal Article)
|
Copyright | © 2023. The Author(s). |
Chemical References |
- Echinocandins
- Caspofungin
- Antifungal Agents
|
Topics |
- Humans
- Echinocandins
(pharmacology, genetics, therapeutic use)
- Candida glabrata
(genetics)
- Caspofungin
(pharmacology)
- Antifungal Agents
(pharmacology, therapeutic use)
- Genome-Wide Association Study
- Microbial Sensitivity Tests
- Candidiasis, Invasive
(drug therapy)
- China
- Drug Resistance, Fungal
(genetics)
|